Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Proteomics International Laboratories Ltd. ( (AU:PIQ) ).
Proteomics International Laboratories Ltd has achieved ISO 15189 certification for its Australian laboratory operations, marking a significant milestone in the commercialization and clinical application of its precision diagnostic tests. This certification enhances the company’s reputation as a global leader in proteomics and protein-based testing services, supporting its strategic growth and enabling the offering of new specialist pathology tests. The certification is expected to open new revenue streams and solidify the company’s position as an innovator in precision diagnostics, particularly in areas like diabetic kidney disease, esophageal cancer, and endometriosis.
The most recent analyst rating on (AU:PIQ) stock is a Sell with a A$0.50 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd, based in Perth, Western Australia, is a leading medical technology company specializing in precision diagnostics and bio-analytical services. The company focuses on proteomics, which involves the large-scale study of proteins’ structure and function, aiming to improve disease treatment through innovative diagnostic tools.
Average Trading Volume: 359,582
Technical Sentiment Signal: Sell
Current Market Cap: A$49.51M
For an in-depth examination of PIQ stock, go to TipRanks’ Overview page.